Literature DB >> 15764192

Antimicrobial treatment of asymptomatic carriers of verocytotoxin-producing Escherichia coli: an empiric study.

Charlotte Jensen1, Peter Schiellerup, Katharina Olsen, Flemming Scheutz, Eskild Petersen, Peter Gerner-Smidt, Kåre Mølbak.   

Abstract

Antimicrobial treatment of acute infection caused by verocytotoxin toxin-producing Escherichia coli (VTEC) is controversial due to risk of inducing haemolytic uraemic syndrome. We review the treatment of 9 persons who experienced serious social problems due to prolonged, asymptomatic carriage of non-O157 VTEC. Eradication of VTEC was successful and without complications.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15764192     DOI： 10.1080/00365540510026427

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  4 in total

1.  Etiology of diarrhea in young children in Denmark: a case-control study.

Authors:  Bente Olesen; Jacob Neimann; Blenda Böttiger; Steen Ethelberg; Peter Schiellerup; Charlotte Jensen; Morten Helms; Flemming Scheutz; Katharina E P Olsen; Karen Krogfelt; Eskild Petersen; Kåre Mølbak; Peter Gerner-Smidt
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  Shiga toxin-producing Escherichia coli in household members of children with hemolytic uremic syndrome.

Authors:  Laura Fernanda Alconcher; Marta Rivas; Lucas Ivan Lucarelli; Jimena Galavotti; Mabel Rizzo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-28       Impact factor: 3.267

3.  Whole-genome sequencing for risk assessment of long-term Shiga toxin-producing Escherichia coli.

Authors:  Johannes K-M Knobloch; Stefan Niemann; Thomas A Kohl; Ulrich Lindner; Martin Nitschke; Friedhelm Sayk; Werner Solbach
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883

4.  Prevalence of genotypic antimicrobial resistance in clinical Shiga toxin-producing Escherichia coli in Norway, 2018 to 2020.

Authors:  Silje N Ramstad; Lin T Brandal; Arne M Taxt; Yngvild Wasteson; Jørgen V Bjørnholt; Umaer Naseer
Journal:  J Med Microbiol       Date:  2021-12       Impact factor: 2.472
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.